Follow
Archibald James Mixson
Archibald James Mixson
Verified email at som.umaryland.edu
Title
Cited by
Cited by
Year
Attention deficit hyperactivity disorder and altered metabolism in 18 kindreds with generalized resistance to thyroid hormone
P Hauser, P Zametkin AJ, Martinez, B Vitiello, EA Matochik, JA, Wiggs, ...
New England Journal of Medicine 238, 997-1001, 1993
552*1993
Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice
QR Chen, D Kumar, SA Stass, AJ Mixson
Cancer Research 59 (14), 3308-3312, 1999
3091999
Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two
R Parrilla, AJ Mixson, JA McPherson, JH McClaskey, BD Weintraub
The Journal of clinical investigation 88 (6), 2123-2130, 1991
2651991
Advances in Delivery Systems for Doxorubicin
N Zhao, M Woodle, AJ Mixson
Journal of Nanomedicine and Nanotechnology 9, 519, 2018
2422018
Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice
LA Lesoon-Wood, WH Kim, HK Kleinman, BD Weintraub, AJ Mixson
Human Gene Therapy 6 (4), 395-405, 1995
2221995
Peptide-based antifungal therapies against emerging infections
A Matejuk, Q Leng, MD Begum, MC Woodle, P Scaria, ST Chou, ...
Drugs of the Future 35 (3), 197, 2010
1962010
Highly branched HK peptides are effective carriers of siRNA
Q Leng, P Scaria, J Zhu, N Ambulos, P Campbell, AJ Mixson
The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2005
1922005
Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity
M Xu, D Kumar, S Srinivas, LJ Detolla, SF Yu, SA Stass, AJ Mixson
Human gene therapy 8 (2), 177-185, 1997
1851997
Angiogenic inhibition mediated by a DNAzyme that targets vascular endothelial growth factor receptor 2
L Zhang, WJ Gasper, SA Stass, OB Ioffe, MA Davis, AJ Mixson
Cancer research 62 (19), 5463-5469, 2002
1442002
Alteration in the IL‐2 signal peptide affects secretion of proteins in vitro and in vivo
L Zhang, Q Leng, AJ Mixson
The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2005
1422005
Thyrotropin-secreting pituitary carcinoma
AJ Mixson, TC Friedman, DA Katz, IM Feuerstein, JK Taubenberger, ...
The Journal of Clinical Endocrinology & Metabolism 76 (2), 529-533, 1993
1391993
Branched co-polymers of histidine and lysine are efficient carriers of plasmids
QR Chen, L Zhang, SA Stass, AJ Mixson
Nucleic acids research 29 (6), 1334-1340, 2001
1302001
Small interfering RNA targeting Raf-1 inhibits tumor growth in vitro and in vivo
Q Leng, AJ Mixson
Cancer gene therapy 12 (8), 682-690, 2005
1172005
Modified branched peptides with a histidine-rich tail enhance in vitro gene transfection
Q Leng, AJ Mixson
Nucleic acids research 33 (4), e40-e40, 2005
1132005
Human rhomboid family-1 gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft tumor growth
Z Yan, H Zou, F Tian, JR Grandis, AJ Mixson, PY Lu, LY Li
Molecular cancer therapeutics 7 (6), 1355-1364, 2008
1112008
Optimal transfection with the HK polymer depends on its degree of branching and the pH of endocytic vesicles
QR Chen, L Zhang, PW Luther, AJ Mixson
Nucleic acids research 30 (6), 1338-1345, 2002
1072002
Branched histidine copolymers and methods for using same
AJ Mixson
US Patent 7,070,807, 2006
1062006
Branched histidine copolymers and methods for using same
AJ Mixson
US Patent 7,070,807, 2006
1062006
Co-polymer of histidine and lysine markedly enhances transfection efficiency of liposomes
QR Chen, L Zhang, SA Stass, AJ Mixson
Gene Therapy 7 (19), 1698-1705, 2000
1012000
Histidine copolymer and methods for using same
AJ Mixson
US Patent 7,163,695, 2007
912007
The system can't perform the operation now. Try again later.
Articles 1–20